← Leaderboards
Helen E Heslop
Baylor College Of Medicine
$25,308,937
Attributed
$31,087,316
Total exposure
72
Grants
65
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$112,599,834 · 75
By mechanism
P50$52,573,740 · 14
P01$37,065,182 · 11
P30$12,967,053 · 13
T32$7,269,233 · 2
UG1$1,835,749 · 1
U10$640,872 · 1
Top collaborators
- Cliona M Rooney35 shared
- Malcolm K Brenner16 shared
- Catherine Mary Bollard9 shared
- Katherine Yudeh King1 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Cliona M Rooney$13,445,584
- Ann M. Leen$2,736,030
- Stephen Gottschalk$13,145,706
- Malcolm K Brenner$13,204,649
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelProgramsClinical ResearchFundingCellsClinical TrialsEnsureMedicineCollegeMonitorLymphomaMalignant NeoplasmsCell TherapyLaboratoriesMemberTumorImmuneGene TherapyT-LymphocyteSafetyBaseResourcesCollaborationsResource Sharing
Grant awards (200)
SPORE in Lymphoma$3,109,934
P50 · FY2025 · CA · contact PI
Training In Cell and Gene Therapy$518,127
T32 · FY2025 · HL · contact PI
BMT CTN Core: Baylor College of Medicine Consortium$230,545
UG1 · FY2025 · HL · contact PI
Administrative Core$182,271
P50 · FY2025 · CA · contact PI
Core B: Clinical Research$147,027
P50 · FY2025 · CA · contact PI
Career Enhancement Program$91,141
P50 · FY2025 · CA · contact PI
Cancer Cell & Gene Therapy Program$52,683
P30 · FY2025 · CA · contact PI
SPORE in Lymphoma$2,075,728
P50 · FY2024 · CA · contact PI
Training In Cell and Gene Therapy$503,875
T32 · FY2024 · HL · contact PI
Developmental Funds$419,048
P30 · FY2024 · CA · contact PI
Leadership, Planning and Evaluation$345,232
P30 · FY2024 · CA · contact PI
BMT CTN Core: Baylor College of Medicine Consortium$242,183
UG1 · FY2024 · HL · contact PI
Cancer Center Administrative Core$212,902
P30 · FY2024 · CA · contact PI
Administrative Core$179,983
P50 · FY2024 · CA · contact PI
Core B: Clinical Research$145,180
P50 · FY2024 · CA · contact PI
Career Enhancement Program$89,996
P50 · FY2024 · CA · contact PI
Cancer Cell and Gene Therapy$32,567
P30 · FY2024 · CA · contact PI
SPORE in Lymphoma$2,048,062
P50 · FY2023 · CA · contact PI
Training In Cell and Gene Therapy$522,265
T32 · FY2023 · HL · contact PI
Developmental Funds$419,048
P30 · FY2023 · CA · contact PI
Leadership, Planning and Evaluation$345,232
P30 · FY2023 · CA · contact PI
Administrative Core$251,330
P50 · FY2023 · CA · contact PI
Cancer Center Administrative Core$212,902
P30 · FY2023 · CA · contact PI
Targeting HIV and EBV Antigens in Patients with HIV Lymphoma$195,745
UG1 · FY2023 · HL · contact PI
Core B: Clinical Research$155,278
P50 · FY2023 · CA · contact PI
Career Enhancement Program$121,275
P50 · FY2023 · CA · contact PI
Empowering Cancer Patient-Provider Communication: A Personal Virtual Assistant for Automated Post-Discharge Engagement$93,600
P30 · FY2023 · CA · contact PI
Cancer Cell and Gene Therapy$32,567
P30 · FY2023 · CA · contact PI
SPORE in Lymphoma$2,062,012
P50 · FY2022 · CA · contact PI
Developmental Funds$419,048
P30 · FY2022 · CA · contact PI
Training In Cell and Gene Therapy$373,273
T32 · FY2022 · HL · contact PI
Leadership, Planning and Evaluation$345,232
P30 · FY2022 · CA · contact PI
Cancer Center Administrative Core$212,902
P30 · FY2022 · CA · contact PI
Targeting HIV and EBV Antigens in Patients with HIV Lymphoma$195,745
UG1 · FY2022 · HL · contact PI
Administrative Core$177,633
P50 · FY2022 · CA · contact PI
Core B: Clinical Research$143,287
P50 · FY2022 · CA · contact PI
Career Enhancement Program$88,826
P50 · FY2022 · CA · contact PI
Baylor College of Medicine Cancer Center-Cancer Center Support Grant$69,560
P30 · FY2022 · CA · contact PI
Cancer Cell and Gene Therapy$32,567
P30 · FY2022 · CA · contact PI
Baylor College of Medicine Cancer Center-Cancer Center Support Grant$3,517,288
P30 · FY2021 · CA · contact PI
SPORE in Lymphoma$2,133,312
P50 · FY2021 · CA · contact PI
Training In Cell and Gene Therapy$382,673
T32 · FY2021 · HL · contact PI
Clinical, Protocol and Data Management$292,343
P30 · FY2021 · CA · contact PI
Baylor College of Medicine Cancer Center-Cancer Center Support Grant$248,541
P30 · FY2021 · CA · contact PI
Targeting HIV and EBV Antigens in Patients with HIV Lymphoma$195,745
UG1 · FY2021 · HL · contact PI
Baylor College of Medicine Cancer Center-Cancer Center Support Grant$175,577
P30 · FY2021 · CA · contact PI
Administrative Core$160,683
P50 · FY2021 · CA · contact PI
Clinical & Biostats Core$157,518
P50 · FY2021 · CA · contact PI
Clinical benefit and cost-efficacy of risk-stratified survivorship navigation to overcome structural barriers to long-term follow-up care$149,836
P30 · FY2021 · CA · contact PI
Career Enhancement Program$96,688
P50 · FY2021 · CA · contact PI
Baylor College of Medicine Cancer Center-Cancer Center Support Grant$60,000
P30 · FY2021 · CA · contact PI
Cancer Cell and Gene Therapy$40,088
P30 · FY2021 · CA · contact PI
Baylor College of Medicine Cancer Center-Cancer Center Support Grant$3,517,288
P30 · FY2020 · CA · contact PI
SPORE in Lymphoma$2,179,484
P50 · FY2020 · CA · contact PI
Baylor College of Medicine Cancer Center-Cancer Center Support Grant$470,361
P30 · FY2020 · CA · contact PI
Training In Cell and Gene Therapy$377,268
T32 · FY2020 · HL · contact PI
Clinical, Protocol and Data Management$302,647
P30 · FY2020 · CA · contact PI
Targeting HIV and EBV Antigens in Patients with HIV Lymphoma$195,745
UG1 · FY2020 · HL · contact PI
Administrative Core$161,288
P50 · FY2020 · CA · contact PI
Clinical & Biostats Core$157,884
P50 · FY2020 · CA · contact PI
Baylor College of Medicine Cancer Center-Cancer Center Support Grant$150,000
P30 · FY2020 · CA · contact PI
Baylor College of Medicine Cancer Center-Cancer Center Support Grant$150,000
P30 · FY2020 · CA · contact PI
Career Enhancement Program$92,479
P50 · FY2020 · CA · contact PI
Cancer Cell and Gene Therapy$32,567
P30 · FY2020 · CA · contact PI
American Society of Gene & Cell Therapy (ASGCT) 21st Annual Meeting$15,000
R13 · FY2020 · TR · contact PI
SPORE in Lymphoma$2,636,949
P50 · FY2019 · CA · contact PI
Training In Cell and Gene Therapy$363,647
T32 · FY2019 · HL · contact PI
Administrative Core$198,383
P50 · FY2019 · CA · contact PI
Targeting HIV and EBV Antigens in Patients with HIV Lymphoma$195,745
UG1 · FY2019 · HL · contact PI
Clinical & Biostats Core$194,477
P50 · FY2019 · CA · contact PI
Career Enhancement Program$119,369
P50 · FY2019 · CA · contact PI
EARLY PHASE CLINICAL RESEARCH SUPPORT (Core-017)$75,790
P30 · FY2019 · CA · contact PI
Cancer Cell and Gene Therapy Program (Project-005)$70,263
P30 · FY2019 · CA · contact PI
American Society of Gene & Cell Therapy (ASGCT) 21st Annual Meeting$15,000
R13 · FY2019 · TR · contact PI
SPORE in Lymphoma$2,297,796
P50 · FY2018 · CA · contact PI
Training In Cell and Gene Therapy$353,720
T32 · FY2018 · HL · contact PI
Targeting HIV and EBV Antigens in Patients with HIV Lymphoma$185,957
UG1 · FY2018 · HL · contact PI
Administrative Core$172,776
P50 · FY2018 · CA · contact PI
Clinical & Biostats Core$169,374
P50 · FY2018 · CA · contact PI
Career Enhancement Program$103,967
P50 · FY2018 · CA · contact PI
EARLY PHASE CLINICAL RESEARCH SUPPORT (Core-017)$71,281
P30 · FY2018 · CA · contact PI
Cancer Cell and Gene Therapy Program (Project-005)$66,213
P30 · FY2018 · CA · contact PI
American Society of Gene & Cell Therapy (ASGCT) 21st Annual Meeting$15,000
R13 · FY2018 · TR · contact PI
EARLY PHASE CLINICAL RESEARCH SUPPORT (Core-017)$10,000
P30 · FY2018 · CA · contact PI
Cancer Cell and Gene Therapy Program (Project-005)$9,999
P30 · FY2018 · CA · contact PI
Cancer Cell and Gene Therapy Program (Project-005)$4,755
P30 · FY2018 · CA · contact PI
EARLY PHASE CLINICAL RESEARCH SUPPORT (Core-017)$4,755
P30 · FY2018 · CA · contact PI
SPORE in Lymphoma$3,097,657
P50 · FY2017 · CA · contact PI
ENHANCING T CELL THERAPY OF CANCER$1,932,287
P01 · FY2017 · CA · contact PI
CELL AND VECTOR PRODUCTION$492,025
P01 · FY2017 · CA · contact PI
VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY$295,519
P01 · FY2017 · CA · contact PI
CHIMERIC T CELLS TARGETING NEUROBLASTOMA$295,506
P01 · FY2017 · CA · contact PI
Training in Cell and Gene Therapy$267,491
T32 · FY2017 · HL · contact PI
Improving T Cell Therapies for Nasopharyngeal Cancer$264,138
P01 · FY2017 · CA · contact PI
ENGINEERING T CELLS FOR PANCREATIC CANCER$254,484
P01 · FY2017 · CA · contact PI
CLINICAL RESEARCH AND BIOSTATISTICS CORE$232,807
P01 · FY2017 · CA · contact PI
Targeting HIV and EBV Antigens in Patients with HIV Lymphoma$198,339
UG1 · FY2017 · HL · contact PI
Clinical & Biostats Core$157,650
P50 · FY2017 · CA · contact PI
Administrative Core$147,186
P50 · FY2017 · CA · contact PI
ADMINISTRATIVE CORE$97,808
P01 · FY2017 · CA · contact PI
Career Enhancement Program$91,783
P50 · FY2017 · CA · contact PI
EARLY PHASE CLINICAL RESEARCH SUPPORT (Core-017)$49,416
P30 · FY2017 · CA · contact PI
Cancer Cell and Gene Therapy Program (Project-005)$43,684
P30 · FY2017 · CA · contact PI
American Society of Gene & Cell Therapy (ASGCT) 20th Annual Meeting$22,000
R13 · FY2017 · TR · contact PI
SPORE in Lymphoma$2,344,258
P50 · FY2016 · CA · contact PI
Enhancing T Cell Therapy of Cancer$1,932,287
P01 · FY2016 · CA · contact PI
CELL AND VECTOR PRODUCTION$492,027
P01 · FY2016 · CA · contact PI
Training in Cell and Gene Therapy$340,721
T32 · FY2016 · HL · contact PI
SPORE in Lymphoma$300,703
P50 · FY2016 · CA · contact PI
VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY$295,517
P01 · FY2016 · CA · contact PI
CHIMERIC T CELLS TARGETING NEUROBLASTOMA$295,508
P01 · FY2016 · CA · contact PI
Improving T Cell Therapies for Nasopharyngeal Cancer$264,136
P01 · FY2016 · CA · contact PI
ENGINEERING T CELLS FOR PANCREATIC CANCER$254,482
P01 · FY2016 · CA · contact PI
CLINICAL RESEARCH AND BIOSTATISTICS CORE$232,809
P01 · FY2016 · CA · contact PI
Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT$160,218
U10 · FY2016 · HL · contact PI
CAREER DEVELOPMENT PROGRAM$155,811
P50 · FY2016 · CA · contact PI
Clinical Research Core$143,969
P50 · FY2016 · CA · contact PI
ADMINISTRATIVE CORE$140,645
P50 · FY2016 · CA · contact PI
ADMINISTRATIVE CORE$97,808
P01 · FY2016 · CA · contact PI
EARLY PHASE CLINICAL RESEARCH SUPPORT (Core-017)$49,416
P30 · FY2016 · CA · contact PI
Cancer Cell and Gene Therapy Program (Project-005)$43,684
P30 · FY2016 · CA · contact PI
SPORE in Lymphoma$2,184,999
P50 · FY2015 · CA · contact PI
Enhancing T Cell Therapy of Cancer$1,932,287
P01 · FY2015 · CA · contact PI
CELL AND VECTOR PRODUCTION$492,025
P01 · FY2015 · CA · contact PI
Training in Cell and Gene Therapy$332,738
T32 · FY2015 · HL · contact PI
VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY$295,515
P01 · FY2015 · CA · contact PI
CHIMERIC T CELLS TARGETING NEUROBLASTOMA$295,506
P01 · FY2015 · CA · contact PI
Improving T Cell Therapies for Nasopharyngeal Cancer$264,141
P01 · FY2015 · CA · contact PI
ENGINEERING T CELLS FOR PANCREATIC CANCER$254,484
P01 · FY2015 · CA · contact PI
CLINICAL RESEARCH AND BIOSTATISTICS CORE$232,808
P01 · FY2015 · CA · contact PI
Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT$160,218
U10 · FY2015 · HL · contact PI
CAREER DEVELOPMENT PROGRAM$157,467
P50 · FY2015 · CA · contact PI
Clinical Research Core$145,501
P50 · FY2015 · CA · contact PI
ADMINISTRATIVE CORE$142,142
P50 · FY2015 · CA · contact PI
ADMINISTRATIVE CORE$97,808
P01 · FY2015 · CA · contact PI
EARLY PHASE CLINICAL RESEARCH SUPPORT (Core-017)$61,663
P30 · FY2015 · CA · contact PI
Cancer Cell and Gene Therapy Program (Project-005)$54,508
P30 · FY2015 · CA · contact PI
Training in Cell and Gene Therapy$11,849
T32 · FY2015 · HL · contact PI
SPORE in Lymphoma$2,162,000
P50 · FY2014 · CA · contact PI
Enhancing T Cell Therapy of Cancer$1,874,319
P01 · FY2014 · CA · contact PI
CELL AND VECTOR PRODUCTION$478,502
P01 · FY2014 · CA · contact PI
Training in Cell and Gene Therapy$328,111
T32 · FY2014 · HL · contact PI
CHIMERIC T CELLS TARGETING NEUROBLASTOMA$287,387
P01 · FY2014 · CA · contact PI
VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY$282,534
P01 · FY2014 · CA · contact PI
Improving T Cell Therapies for Nasopharyngeal Cancer$256,879
P01 · FY2014 · CA · contact PI
ENGINEERING T CELLS FOR PANCREATIC CANCER$247,486
P01 · FY2014 · CA · contact PI
CLINICAL RESEARCH AND BIOSTATISTICS CORE$226,411
P01 · FY2014 · CA · contact PI
Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT$160,218
U10 · FY2014 · HL · contact PI
CAREER DEVELOPMENT PROGRAM$155,809
P50 · FY2014 · CA · contact PI
Clinical Research Core$143,969
P50 · FY2014 · CA · contact PI
ADMINISTRATIVE CORE$140,646
P50 · FY2014 · CA · contact PI
ADMINISTRATIVE CORE$95,120
P01 · FY2014 · CA · contact PI
SPORE in Lymphoma$2,150,500
P50 · FY2013 · CA · contact PI
Enhancing T Cell Therapy of Cancer$1,932,287
P01 · FY2013 · CA · contact PI
Training in Cell and Gene Therapy$298,046
T32 · FY2013 · HL · contact PI
Clinical Research and Biostatistics Core$233,412
P01 · FY2013 · CA · contact PI
Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT$160,218
U10 · FY2013 · HL · contact PI
CAREER DEVELOPMENT PROGRAM$152,165
P50 · FY2013 · CA · contact PI
Clinical Research Core$139,568
P50 · FY2013 · CA · contact PI
ADMINISTRATIVE CORE$136,032
P50 · FY2013 · CA · contact PI
Administrative Core$98,062
P01 · FY2013 · CA · contact PI
SPORE in Lymphoma$2,300,000
P50 · FY2012 · CA · contact PI
Enhancing T Cell Therapy of Cancer$1,916,364
P01 · FY2012 · CA · contact PI
Training in Cell and Gene Therapy$248,781
T32 · FY2012 · HL · contact PI
ADMINISTRATIVE AND CLINICAL RESEARCH$241,603
P01 · FY2012 · CA · contact PI
CAREER DEVELOPMENT PROGRAM$165,755
P50 · FY2012 · CA · contact PI
Clinical Research Core$153,159
P50 · FY2012 · CA · contact PI
ADMINISTRATIVE CORE$149,624
P50 · FY2012 · CA · contact PI
SPORE in Lymphoma$2,153,287
P50 · FY2011 · CA · contact PI
Enhancing T Cell Therapy of Cancer$1,924,347
P01 · FY2011 · CA · contact PI
Training in Cell and Gene Therapy$296,642
T32 · FY2011 · HL · contact PI
ADMINISTRATIVE AND CLINICAL RESEARCH$243,346
P01 · FY2011 · CA · contact PI
Career Development$152,964
P50 · FY2011 · CA · contact PI
Clinical Research Core$66,675
P50 · FY2011 · CA · contact PI
MOST CLOSELY HLA MATCHED ALLOGENEIC VIRUS SPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL)$1,979
M01 · FY2011 · RR · contact PI
CLINICAL TRIAL: ADMINISTRATION OF EBV SPECIFIC CYTOTOXIC T LYMPHOCYTES TO RECIPI$1,187
M01 · FY2011 · RR · contact PI
SPORE in Lymphoma$2,266,618
P50 · FY2010 · CA · contact PI
Enhancing T Cell Therapy of Cancer$1,992,319
P01 · FY2010 · CA · contact PI
SPORE in Lymphoma$340,000
P50 · FY2010 · CA · contact PI
Training in Cell and Gene Therapy$292,288
T32 · FY2010 · HL · contact PI
ADMINISTRATIVE AND CLINICAL RESEARCH$252,050
P01 · FY2010 · CA · contact PI
Career Development$184,258
P50 · FY2010 · CA · contact PI
Clinical Research Core$81,464
P50 · FY2010 · CA · contact PI
MOST CLOSELY HLA MATCHED ALLOGENEIC VIRUS SPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL)$4,197
M01 · FY2010 · RR · contact PI
PROCUREMENT OF TISSUE FOR MAKING EPSTEIN-BARR VIRUS (EBV) SPECIFIC CYTOTOXIC T$1,145
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR EBV-POSITIVE NASOPHARYN$763
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: ADMINISTRATION OF EBV SPECIFIC CYTOTOXIC T LYMPHOCYTES TO RECIPI$763
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: AUTOLOGOUS EBV SPECIFIC CTLS FOR THERAPY OF SEVERE CHRONIC EBV I$381
M01 · FY2010 · RR · contact PI
SPORE in Lymphoma$2,266,618
P50 · FY2009 · CA · contact PI
Enhancing T Cell Therapy of Cancer$1,961,712
P01 · FY2009 · CA · contact PI
SPORE in Lymphoma$371,941
P50 · FY2009 · CA · contact PI
Training in Cell and Gene Therapy$290,149
T32 · FY2009 · HL · contact PI
ADMINISTRATIVE AND CLINICAL RESEARCH$248,296
P01 · FY2009 · CA · contact PI
Career Development$185,587
P50 · FY2009 · CA · contact PI
Clinical Research Core$83,249
P50 · FY2009 · CA · contact PI
SPORE in Lymphoma$59,392
P50 · FY2009 · CA · contact PI
Enhancing T Cell Therapy of Cancer$59,392
P01 · FY2009 · CA · contact PI
CLINICAL TRIAL: EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR EBV-POSITIVE NASOPHARYN$3,851
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: AUTOLOGOUS EBV SPECIFIC CTLS FOR THERAPY OF SEVERE CHRONIC EBV I$2,666
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: ADMINISTRATION OF EBV SPECIFIC CYTOTOXIC T LYMPHOCYTES TO RECIPI$1,185
M01 · FY2009 · RR · contact PI